340B Insight Podcast
340B Insight is 340B Health’s podcast, providing our members and supporters with timely news updates and discussion around the 340B drug pricing program. The podcast enables listeners to stay current and expand their knowledge of 340B to help them serve their patients and communities and remain compliant with rules and requirements. New episodes are published twice per month and include news update segments and in-depth interviews with leading experts including health care practitioners, policy and legal experts, public policymakers, and our expert staff.
Have a question or suggestion for 340B Insight? Email us at: podcast@340bhealth.org
Follow 340B Health on Twitter, Facebook, and LinkedIn
Episodes
-
Episode 25: Maureen Testoni on Top 340B Developments
This week we are joined by Maureen Testoni, 340B Health’s president and CEO. Maureen provides her expert analysis on the top 340B developments from the first quarter of 2021. The conversation includes the latest on drug manufacturers denying 340B discounts on drugs dispensed at community pharmacies, attempts to turn 340B into a rebate program, and payers and pharmacy benefit managers making mandatory changes to their claims processes. Maureen also shares positive recent developments on advocating for 340B. (Transcript)
Read more -
Episode 24: 340B in the World of Cancer Treatment
April is National Cancer Control Month, and this week we are joined by Dr. Gerold Bepler, president and CEO at the Barbara Ann Karmanos Cancer Institute in Detroit. Dr. Bepler discusses the unique role cancer centers play in preventing and treating cancer, the importance of 340B to Karmanos and its patients, how Karmanos is addressing racial and ethnic disparities in cancer treatment, and the partnership it has formed to expand access to cancer research and treatment in rural communities. Before the interview, we recap 340B Health’s recent virtual Hill Day. (Transcript)
Read moreThis Episode is Sponsored By
-
Episode 23: How State Policy Affects 340B
This week we are joined by Amanda Sellers Smith, the assistant counsel for 340B Health. While 340B is a federal program, it is intertwined with Medicaid and states’ oversight of the health care marketplace. Amanda discusses how states are protecting 340B covered entities from discriminatory reimbursement, why changes to state Medicaid policy can affect 340B in multiple ways, and how listeners can advocate for 340B at the state level. Before the interview with Amanda, we recap the results of the newly released 340B Health annual survey of 340B hospitals. (Transcript)
Read moreThis Episode is Sponsored By
-
Episode 22: Ryan White Clinics and Their Importance to the 340B Community
This week we are joined by Dr. John Carlo, CEO of Prism Health North Texas. Prism Health is a Ryan White Clinic, which are grantees of the Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS program. They provide care to patients at risk of or living with HIV/AIDS and are one of 16 types of 340B covered entities. John discusses 340B’s role in Prism Health’s ability to care for patients, how Ryan White Clinics work together with 340B hospitals, how they are serving patients during the pandemic, and the latest innovations in HIV care. Before the interview, we share important updates related to drug company denials of 340B discounts to covered entities that partner with community pharmacies. (Transcript)
Read moreThis Episode is Sponsored By
-
Episode 21: Pursuing Health Equity: Part Two
This week we continue our two-part series focused on how 340B hospitals are pursuing health equity. In our recently released Health Equity Report, 340B Health profiled nine hospitals working to eliminate health disparities in their communities. Today, we continue sharing the stories of three hospitals from that report. For this episode, we are broadcasting from our virtual booth in the exhibit hall at the 340B Coalition Winter Conference that started Feb. 16 and will run through Feb. 24.
After we recorded this episode, a federal judge granted the government’s motion to dismiss a joint lawsuit that 340B Health and other plaintiffs had filed over drug company refusals to offer 340B pricing on drugs dispensed at community pharmacies. Read our statement about the decision, and we will provide additional analysis of the decision in upcoming episodes.
We sit down this week with health equity leaders from each of the three hospitals: Rukiya Curvey Johnson, director of community health and engagement at Rush University System for Health in Chicago; Dr. Cheryl Clark, director of health equity, research and intervention at Brigham and Women’s Hospital’s Center for Community Health and Health Equity in Boston; and Greta Todd, executive director of diversity inclusion and community affairs at St. Louis Children’s Hospital. (Transcript)
Read moreThis Episode is Sponsored By
-
Episode 20: Pursuing Health Equity
This week, we begin a two-part series focused on how 340B hospitals are pursuing health equity. The COVID-19 pandemic has spotlighted the significant racial and ethnic disparities in health care and patient health outcomes. Today, we focus on three hospitals featured in 340B Health’s recently released health equity report and hear more about how they’re working to eliminate health disparities in their communities. Before we launch into the episode, we answer a member question about the many lawsuits that have been filed related to disputes over 340B contract pharmacies.
We sit down with representatives from three hospitals: Dr. Cheryl Clark, director of health equity, research and intervention at Brigham and Women’s Hospital; Rukiya Curvey Johnson, director of community health and engagement at Rush University System for Health in Chicago; Julia Bassett, manager of health and community benefit at Rush; and Greta Todd, executive director of diversity inclusion and community affairs at St. Louis Children’s Hospital. (Transcript)
Read moreThis Episode is Sponsored By